ClinicalTrials.govpublic full text
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
her2-positive breast cancer, her2+ breast cancer, breast cancer, cardiotoxicity, heart failure, cardio-oncology, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843692
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.